Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RENEW-CKD: Phase 3 study of HRS-7535 in chronic kidney disease
CTR20262817Phase 3Active
- Sponsor
- Shandong Sende
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of HRS-7535 in chronic kidney disease (CKD), sponsored by Shandong Sende. Started Jul 2026; status: active.
02
Drugs
HRS-7535
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on CTR20262817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262817.